Israeli Company Joins U.S. Trial on Ulcerative Colitis Treatment
Israeli company Evinature's CurQD, a curcumin and QingDai blend, will be part of a US trial at Mount Sinai and University of Chicago for ulcerative colitis.
Mount Sinai Hospital
Israeli Company Joins U.S. Trial on Ulcerative Colitis Treatment
Israeli firm Evinature's CurQD will be part of a U.S. DoD trial for ulcerative colitis, involving Mount Sinai and University of Chicago.
Navigation